Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,957.00
Bid: 1,956.00
Ask: 1,958.00
Change: 27.00 (1.40%)
Spread: 2.00 (0.102%)
Open: 1,947.00
High: 1,957.00
Low: 1,926.00
Prev. Close: 1,930.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATING CHANGES: Brokers Raise View On Mitchell & Butlers

Wed, 27th Nov 2013 10:14

LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:
----------
FTSE 100
----------
NOMURA RAISES AVIVA PRICE TARGET TO 489 (474) PENCE - 'BUY'
----------
HSBC RAISES AVIVA PRICE TARGET TO 480 (400) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS TESCO PRICE TARGET TO 315 (335) PENCE - 'UNDERWEIGHT'
----------
COMMERZBANK RAISES IAG PRICE TARGET TO 5.10 (4.10) EUR - 'BUY'
----------
GOLDMAN CUTS SEVERN TRENT PRICE TARGET TO 2110 (2113) PENCE - 'BUY'
----------
HSBC CUTS RSA INSURANCE PRICE TARGET TO 115 (128) PENCE - 'NEUTRAL'
----------
HSBC RAISES LEGAL & GENERAL PRICE TARGET TO 250 (230) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES PRUDENTIAL PRICE TARGET TO 1550 (1460) PENCE - 'OVERWEIGHT'
----------
MS RAISES LAND SECURITIES PRICE TARGET TO 1040 (1020) PENCE - 'OVERWEIGHT'
----------
KEPLER CHEUVREUX RAISES WPP PRICE TARGET TO 1525 (1400) PENCE - 'BUY'
----------
PANMURE RAISES COMPASS GROUP PRICE TARGET TO 900 (820) PENCE - 'HOLD'
----------
CANACCORD CUTS RIO TINTO PRICE TARGET TO 4000 (4100) PENCE - 'BUY'
----------
FTSE 250
----------
NOMURA RAISES MITCHELLS & BUTLERS PRICE TARGET TO 390 (370) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES MITCHELLS & BUTLERS TO 'NEUTRAL' ('UNDERWEIGHT')
----------
PANMURE RAISES MITCHELLS & BUTLERS PRICE TARGET TO 365 (310) PENCE - 'SELL'
----------
UBS CUTS MITIE GROUP TO 'NEUTRAL' ('BUY') - TARGET 320 (305) PENCE
----------
BARCLAYS RAISES BRITVIC TO 'OVERWEIGHT' ('EQUAL WEIGHT') - TARGET 690 (560) P.
----------
BARCLAYS CUTS LADBROKES PRICE TARGET TO 188 (218) PENCE - 'EQUAL WEIGHT'
----------
DEUTSCHE BANK CUTS ESSAR ENERGY PRICE TARGET TO 75 (175) - 'HOLD'
----------
DEUTSCHE BANK RAISES BTG PRICE TARGET TO 570 (500) PENCE - 'BUY'
----------
CITIGROUP RAISES DS SMITH PRICE TARGET TO 340 (300) PENCE - 'BUY'
----------
CITIGROUP CUTS DE LA RUE TO 'NEUTRAL' ('BUY') - TARGET 1000 (1055) PENCE
----------
PANMURE RAISES DE LA RUE PRICE TARGET TO 806 (786) PENCE - 'HOLD'
----------
GOLDMAN RAISES HIKMA PRICE TARGET TO 1200 (1180) PENCE - 'NEUTRAL'
----------
HSBC CUTS DIRECT LINE PRICE TARGET TO 248 (250) PENCE - 'NEUTRAL'
----------
LIBERUM RAISES SHAFTESBURY PRICE TARGET TO 636 (622) PENCE - 'HOLD'
----------
PANMURE RAISES BTG PRICE TARGET TO 610 (490) PENCE - 'BUY'
----------
ALL-SHARE AND AIM
----------
PANMURE RAISES INNOVATION GROUP PRICE TARGET TO 44 (41) PENCE - 'BUY'
----------
CANACCORD CUTS IGAS ENERGY PRICE TARGET TO 180 (181) PENCE - 'BUY'
----------
Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
30 Apr 2021 07:57

LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises

LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises

Read more
30 Apr 2021 07:38

Hikma predicts generics revenue at top of guidance

(Sharecast News) - Hikma Pharmaceutical said it made a good start to 2021 and that annual revenue from generic treatments would be at the top of guidance.

Read more
23 Apr 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
21 Apr 2021 12:08

LONDON MARKET MIDDAY: Stocks recover modestly; Netflix misses targets

LONDON MARKET MIDDAY: Stocks recover modestly; Netflix misses targets

Read more
21 Apr 2021 10:06

Hikma resumes asthma drug launch, Vectura pays special dividend

Hikma resumes asthma drug launch, Vectura pays special dividend

Read more
21 Apr 2021 09:01

LONDON MARKET OPEN: Stocks rise; Just Eat sinks on Germany competition

LONDON MARKET OPEN: Stocks rise; Just Eat sinks on Germany competition

Read more
21 Apr 2021 07:52

LONDON MARKET PRE-OPEN: Anto holds outlook, BHP cuts coal guidance

LONDON MARKET PRE-OPEN: Anto holds outlook, BHP cuts coal guidance

Read more
21 Apr 2021 07:30

Hikma resumes US launch of 'Advair Diskus' generic

(Sharecast News) - Hikma Pharmaceuticals has resumed the launch of its generic version of GlaxoSmithKline's 'Advair Diskus' in the United States, it announced on Wednesday, following Food and Drug Administration (FDA) approval of an amendment it submitted to its Abbreviated New Drug Application in January.

Read more
19 Apr 2021 16:02

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
16 Apr 2021 14:54

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
31 Mar 2021 17:04

LONDON MARKET CLOSE: Stocks end lower; investors shun Deliveroo

LONDON MARKET CLOSE: Stocks end lower; investors shun Deliveroo

Read more
31 Mar 2021 13:40

Wednesday broker round-up

(Sharecast News) - Hikma: Jefferies upgrades to buy with a target price of 2,870p.

Read more
31 Mar 2021 12:17

LONDON MARKET MIDDAY: Biden spends big; Deliveroo dives on debut

LONDON MARKET MIDDAY: Biden spends big; Deliveroo dives on debut

Read more
31 Mar 2021 11:56

Jefferies upgrades Hikma to 'buy'

(Sharecast News) - Analysts at Jefferies upgraded drugmaker Hikma Pharmaceuticals from 'hold' to 'buy' on Wednesday, stating the group's share price was yet to reflect "a series of upcoming product catalysts".

Read more
31 Mar 2021 09:37

BROKER RATINGS: BP cut by Morgan Stanley; Jefferies raises Hikma

BROKER RATINGS: BP cut by Morgan Stanley; Jefferies raises Hikma

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.